Long-term use of ticagrelor in patients with prior myocardial infarction.

Author
:
MP Bonaca
DL Bhatt
M Cohen
PG Steg
RF Storey
EC Jensen
G Magnani
S Bansilal
MP Fish
K Im
O Bengtsson
Oude Ophuis
A Budaj
P Theroux
M Ruda
C Hamm
S Goto
J Spinar
JC Nicolau
RG Kiss
SA Murphy
SD Wiviott
P Held
E Braunwald
MS Sabatine
Investigators. and
Abstract
:

The potential benefit of dual antiplatelet therapy beyond 1 year after a myocardial infarction has not been established. We investigated the efficacy and safety of ticagrelor, a P2Y12 receptor antagonist with established efficacy after an acute coronary syndrome, in this context.
Year of Publication
:
2015
Journal
:
The New England journal of medicine
Volume
:
372
Issue
:
19
Number of Pages
:
1791-800
Date Published
:
2015
ISSN Number
:
0028-4793
URL
:
https://www.nejm.org/doi/10.1056/NEJMoa1500857?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dwww.ncbi.nlm.nih.gov
DOI
:
10.1056/NEJMoa1500857
Short Title
:
N Engl J Med
Download citation